News
Nanotechnology shows early promise to treat cardiovascular disease A new tactic in the battle against cardiovascular disease - employing nanoengineered molecules called "nanolipoblockers" as frontline infantry against harmful cholesterol - is showing promise in early laboratory studies at Rutgers, The State University of New Jersey.
|